Report Library
View More
Datamonitor Healthcare CNS Disease ...
April 7, 2026
Acute Lymphoblastic Leukemia KOL In...
April 1, 2026
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Datamonitor Healthcare CV&Met: Veno...
March 10, 2026
Datamonitor Healthcare CV&Met: Atri...
March 10, 2026
Datamonitor Healthcare Oncology: Sm...
March 10, 2026
Datamonitor Healthcare I&I: Glaucom...
March 10, 2026
Bio Asia 2026 Conference Dispatch
March 9, 2026
Datamonitor Healthcare CV&Met: Isch...
March 4, 2026
Datamonitor Healthcare CV&Met: Chem...
March 4, 2026
Datamonitor Healthcare Other: Erect...
March 4, 2026
Datamonitor Healthcare Other: Hypog...
March 4, 2026
Datamonitor Healthcare CV&Met: Amyl...
March 4, 2026
Datamonitor Healthcare Oncology: Tu...
March 4, 2026
Datamonitor Healthcare CNS: Neuropa...
March 4, 2026
Datamonitor Healthcare Oncology: Me...
March 4, 2026
Cystic Fibrosis (CF) KOL Interview ...
March 2, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 4/2/26 | AstraZeneca (AZN) | Imfinzi for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/2/26 | AstraZeneca (AZN) | Imjudo for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/30/26 | Ferrer | Tyvaso for Pulmonary Fibrosis | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/30/26 | Ferrer | Tyvaso for Idiopathic Pulmonary Fibrosis (IPF) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/30/26 | Merck & Co. (MRK) | enlicitide decanoate for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |